Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Amlorine 5, 5 mg tablets.
Amlorine 10, 10 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Amlorine 5, 5mg tablets: White, round, normal convex tablets. Amlorine 10, 10 mg tablets: White, round, normal convex tablets, scored on one side. The tablet can be divided into equal doses. |
Amlorine 5, 5 mg tablets: Each tablet contains amlodipine besilate equivalent to 5 mg amlodipine.
Amlorine 10, 10 mg tablets: Each tablet contains amlodipine besilate equivalent to 10 mg amlodipine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Amlodipine |
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
PVC-PE-PVDC/Aluminium blisters.
Pack-sizes of 10, 20, 30, 50, and 100 tablets.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Amlorine 5, 5 mg tablets: 20258
Amlorine 10, 10 mg tablets: 20259
Amlorine 5, 5 mg tablets:
Date of first authorisation: 29 August 2007
Date of latest renewal: 16 January 2013
Amlorine 10, 10 mg tablets:
Date of first authorisation: 29 August 2007
Date of latest renewal: 20 May 2013
| Drug | Countries | |
|---|---|---|
| AMLORINE | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
